Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-02

Clinical Trial Update: Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid [NA]

View source ↗

Summary

This document reports a completed clinical trial comparing Tripterygium wilfordii plus steroids versus tacrolimus plus steroids for idiopathic membranous nephro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)
  • Tripterygium wilfordii (Tripterygium wilfordii)

Snippet

Sponsor: Zhi-Hong Liu, M.D. | Conditions: Idiopathic Membranous Nephropathy | NA | Status: COMPLETED